Fabtech Technologies Cleanrooms Ltd
Incorporated in 2015, Fabtech Technologies Cleanrooms Limited is a global company specializing in turnkey engineering solutions for the pharmaceutical, biotech, and healthcare sectors.[1]
- Market Cap ₹ 427 Cr.
- Current Price ₹ 347
- High / Low ₹ 470 / 203
- Stock P/E 43.3
- Book Value ₹ 80.8
- Dividend Yield 0.58 %
- ROCE 13.1 %
- ROE 10.2 %
- Face Value ₹ 10.0
Pros
Cons
- Company has a low return on equity of 12.4% over last 3 years.
- Company has high debtors of 153 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Manufacturing Industrial Products
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 86 | 65 | 107 | 114 | 83 | 139 | 142 | |
| 80 | 64 | 101 | 101 | 75 | 123 | 129 | |
| Operating Profit | 6 | 1 | 6 | 12 | 8 | 16 | 12 |
| OPM % | 7% | 2% | 5% | 11% | 10% | 11% | 9% |
| 1 | 0 | 0 | 0 | 1 | 1 | 0 | |
| Interest | 1 | 0 | 1 | 1 | 1 | 0 | 1 |
| Depreciation | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 6 | 0 | 5 | 11 | 7 | 16 | 11 |
| Tax % | 29% | -52% | 35% | 28% | 28% | 24% | 21% |
| 4 | 1 | 3 | 8 | 5 | 12 | 9 | |
| EPS in Rs | 1,310.00 | 233.33 | 11.49 | 29.07 | 18.88 | 9.77 | 7.35 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 20% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 8% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 70% |
| 3 Years: | 7% |
| TTM: | -17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 12% |
| Last Year: | 10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 12 | 12 |
| Reserves | 32 | 32 | 35 | 44 | 49 | 81 | 87 |
| 10 | 7 | 8 | 6 | 5 | 0 | 16 | |
| 21 | 25 | 32 | 23 | 24 | 24 | 43 | |
| Total Liabilities | 66 | 67 | 79 | 75 | 81 | 117 | 158 |
| 3 | 3 | 3 | 3 | 4 | 3 | 3 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Investments | 3 | 3 | 3 | 3 | 4 | 28 | 22 |
| 60 | 60 | 72 | 69 | 73 | 86 | 132 | |
| Total Assets | 66 | 67 | 79 | 75 | 81 | 117 | 158 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| -9 | 4 | 3 | 8 | 4 | 2 | -11 | |
| 2 | -1 | -4 | -3 | -2 | -25 | -4 | |
| 7 | -3 | 1 | -4 | -2 | 24 | 12 | |
| Net Cash Flow | 1 | -1 | 0 | 1 | 0 | 1 | -3 |
| Free Cash Flow | -10 | 3 | 3 | 8 | 2 | 1 | -14 |
| CFO/OP | -123% | 354% | 67% | 84% | 84% | 39% | -71% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 188 | 236 | 172 | 149 | 203 | 132 | 153 |
| Inventory Days | 54 | 85 | 52 | 45 | 82 | 58 | 124 |
| Days Payable | 108 | 139 | 96 | 69 | 105 | 67 | 94 |
| Cash Conversion Cycle | 134 | 183 | 127 | 124 | 179 | 123 | 183 |
| Working Capital Days | 115 | 152 | 94 | 101 | 156 | 128 | 132 |
| ROCE % | 2% | 13% | 25% | 15% | 22% | 13% |
Insights
In beta| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Installed Manufacturing Space sq. ft. |
|
||
| Consolidated Order Book ₹ Crores |
|||
| Total Employee Count Number |
|||
| Number of Clients Nodes |
|||
| Order Pipeline (Leads) ₹ Crores |
|||
| Panel Manufacturing Capacity Utilization % |
|||
| Revenue Mix - Non-Pharma % |
|||
| Revenue Mix - Pharma % |
|||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
23 May - Received ₹65.10 crore domestic order for modular cleanroom systems from solar PV module manufacturer, executable by Nov 30, 2026.
-
Corporate Announcement On Order Booking And Update
12 May - April 2026 orders total ₹70.82 crore; order book at ₹229.25 crore, including ₹29.25 crore HVAC LOI.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
12 May - Please find attached Transcript of Earning Call held on Tuesday, 5th May, 2026 .
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
5 May - Posted video recording link for May 5, 2026 earnings call on audited FY26 results.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
30 Apr - Intimation regarding Newspaper Publication for Audited Financial Result of the company for Second half Year ended and Year ended March 31, 2026.
Annual reports
Concalls
-
May 2026Transcript PPT
-
Nov 2025Transcript PPT
-
Jun 2025TranscriptPPT
-
Mar 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
Business Overview[1]
Fabtech Technologies Cleanrooms specializes in manufacturing and providing end-to-end solutions for pre-engineered and pre-fabricated modular panels and doors for cleanrooms. These cleanrooms are used in pharmaceutical, healthcare, and biotech sectors and adhere to global regulatory standards like ISO and FDA. The company offers services including design, engineering, manufacturing, quality assurance, installation, and validation.